---
figid: PMC1828071__nihms16392f1a
figtitle: Intracellular Signaling in Insulin-mediated Regulation of Drug Metabolizing
  Enzyme Gene and Protein Expression
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC1828071
filename: nihms16392f1a.jpg
figlink: /pmc/articles/PMC149053/figure/fig7/
number: F1a
caption: Fig. 1A Insulin-mediated signaling pathways. A diagrammatic representation
  of insulin and growth factor receptor mediated signaling with effects on gene transcription,
  through phosphorylation of the FOXO1, 3a and 4 transcription factors, and mRNA translation,
  through 4E-PB1, p70 S6 kinase, eIF4B, S6 ribosomal protein, and eIF4G.Fig. 1B Glucagon-mediated
  signaling pathways. A diagrammatic representation of glucagon mediated signaling
  through the adenylate cyclase, cAMP, PKA, AMPK pathway with inhibitory effects on
  mTOR and the transcription factors HNF1alpha and HNF4alpha. The opposing effects
  of glucagon on insulin-mediated alterations in gene expression may occur through
  glucagon repression of insulin signaling through mTOR, which is associated with
  activation of PKA, the phosphorylation of LKB1, and activation of AMPK. Glucagon
  also represses activation of the phosphorylation of 4E-B P1 and the p70S6 kinase.
papertitle: The Role of Intracellular Signaling in Insulin-mediated Regulation of
  Drug Metabolizing Enzyme Gene and Protein Expression.
reftext: Sang K. Kim, et al. Pharmacol Ther. ;113(1):88-120.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9356666
figid_alias: PMC1828071__F1a
figtype: Figure
redirect_from: /figures/PMC1828071__F1a
ndex: d5a528b0-df06-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC1828071__nihms16392f1a.html
  '@type': Dataset
  description: Fig. 1A Insulin-mediated signaling pathways. A diagrammatic representation
    of insulin and growth factor receptor mediated signaling with effects on gene
    transcription, through phosphorylation of the FOXO1, 3a and 4 transcription factors,
    and mRNA translation, through 4E-PB1, p70 S6 kinase, eIF4B, S6 ribosomal protein,
    and eIF4G.Fig. 1B Glucagon-mediated signaling pathways. A diagrammatic representation
    of glucagon mediated signaling through the adenylate cyclase, cAMP, PKA, AMPK
    pathway with inhibitory effects on mTOR and the transcription factors HNF1alpha
    and HNF4alpha. The opposing effects of glucagon on insulin-mediated alterations
    in gene expression may occur through glucagon repression of insulin signaling
    through mTOR, which is associated with activation of PKA, the phosphorylation
    of LKB1, and activation of AMPK. Glucagon also represses activation of the phosphorylation
    of 4E-B P1 and the p70S6 kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Lamtor2
  - drk
  - Crk
  - .na.character
  - dock
  - Nckx30C
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - l(1)G0020
  - Taf4
  - Rpn2
  - Sap-r
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Sos
  - Pdk1
  - ras
  - Ras64B
  - Ras85D
  - pico
  - cass
  - Akt
  - sgg
  - Pk34A
  - Raf
  - gig
  - Tsc1
  - Rheb
  - raptor
  - Mtor
  - Tor
  - rictor
  - Dsor1
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - 'On'
  - Lkb1
  - WDR79
  - tral
  - rump
  - MED17
  - SF1
  - Irbp
  - S6k
  - eIF4B
  - SNF4Agamma
  - AMPKalpha
  - Erk7
  - rl
  - CG9932
  - eIF4A
  - CG7483
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - eIF4G2
  - eIF4G1
  - foxo
  - ff
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - IGF1
  - CDKN2A
  - S100A9
  - CDK2AP2
  - SUB1
  - RPP14
  - LAMTOR2
  - SF3B6
  - H3P8
  - GRB2
  - CRK
  - NCK1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CUX1
  - SART3
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - XYLT2
  - SOS1
  - SOS2
  - PDK1
  - PDPK1
  - PDK2
  - KRAS
  - HRAS
  - NRAS
  - GRB10
  - BAD
  - AKT1
  - AKT2
  - AKT3
  - GSK3A
  - RAF1
  - TSC2
  - TSC1
  - CCL26
  - PDE3B
  - RHEB
  - RHEBP1
  - MTG1
  - MTOR
  - RICTOR
  - MAP2K1
  - MAP2K2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - STK11
  - ANXA6
  - UBASH3B
  - RPS6KB1
  - EIF4B
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - EPHB2
  - MAPK1
  - MAPK3
  - EIF4A1
  - EIF4A2
  - EIF4A3
  - EIF4E
  - EIF4E2
  - EIF4E3
  - DLX4
  - EIF4EBP1
  - EIF4G1
  - EIF4G2
  - EIF4G3
  - FOXO4
  - FOXO1
  - FOXO3
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
